Physician profile
Jonathan D Forman
NPI 1144259078
$2,755.74
in general payments reported to CMS, 2019-2025
24 companies · $419 in 2025
The $419 reported for 2025 was more than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,014 · 2020: $69.25 · 2021: $500 · 2022: $154 · 2023: $428 · 2024: $172 · 2025: $419.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,019.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,018.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $868.42 | 2019-2023 | Xeomin |
| Aerin Medical INC. | $460.48 | 2019-2024 | |
| Depuy Synthes Sales INC. | $292.96 | 2023-2025 | Matrixmandible, Na |
| Spirair, INC. | $153.59 | 2025 | Septalign, Turbalign |
| Stryker Corporation | $133.88 | 2019-2020 | |
| Genzyme Corporation | $118.07 | 2021-2025 | |
| Xoran Technologies LLC | $104.28 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $102.35 | 2021-2024 | Dupixent |
| Optinose US, INC. | $60.99 | 2019-2025 | |
| Integra Lifesciences Corporation | $59.29 | 2024-2025 | Acclarent Aera, Inspira Air, Trudi Probe |
| Acclarent, INC | $56.26 | 2019-2023 | Trudi Nav Cable |
| Organogenesis INC. | $56.07 | 2023-2024 | Puraply |
| Acera Surgical, INC. | $48.74 | 2022-2024 | Restrata Wound Matrix |
| Glaxosmithkline, LLC. | $38.11 | 2022 | |
| W. L. Gore & Associates, INC. | $36.98 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $30.90 | 2021-2022 | |
| Genentech USA, INC. | $22.00 | 2022 | |
| Eyevance Pharmaceuticals LLC | $21.40 | 2021 | |
| Medtronic USA, INC. | $18.06 | 2019 | |
| Watermark Medical, INC. | $17.34 | 2024 | |
| Hikma Pharmaceuticals USA | $17.27 | 2025 | Ryaltris |
| Checkpoint Surgical, INC | $14.33 | 2021 | |
| Arbor Pharmaceuticals, INC. | $12.14 | 2021 | |
| Smith+Nephew, INC. | $11.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Forman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.